Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.
Description | Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor. |
In vitro | Upamostat is an inhibitor of urokinase plasminogen activator (uPA). Upamostat is the oral prodrug of the active metabolite WX-UK1, a novel inhibitor of uPA [1]. Upamostat inhibits the urokinase-type plasminogen activator (uPA) system, and plays a major role in tumor invasion and metastasis. Upamostat is the orally available amidoxime- (i.e. hydroxyamidine-) prodrug of the pharmacologically active form, WX-UK1 [2]. |
Molecular Weight | 629.81 |
Formula | C32H47N5O6S |
CAS No. | 590368-25-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 250 mg/mL (396.95 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Upamostat 590368-25-5 代谢 蛋白酶体 细胞周期 PAI-1 Serine Protease Serine/threonin kinase inhibit Threonine proteases WX 671 Inhibitor Ser/Thr Protease Plasminogen activator inhibitor-1 Serine endopeptidases WX-671 WX671 Serine proteases inhibitor